Dr. Raymond J. Rishwain, DDS in Stockton, California

In 2025, neurology is shifting toward earlier, more personalized, and less invasive care that meaningfully improves daily life. Blood-based biomarkers and AI-enhanced imaging are speeding diagnosis and helping match patients to the right treatments, while disease‑modifying options are expanding—from anti‑amyloid therapies for Alzheimer’s and genetics‑guided approaches in ALS to next‑generation therapies for MS and new migraine preventives. Targeted neuromodulation and wearable monitoring are reducing symptoms and hospital visits in epilepsy and movement disorders, and stroke care is faster and more effective with streamlined thrombolysis, improved thrombectomy, and home‑based rehabilitation. For patients, caregivers, and information seekers, these advances translate into clearer choices, more care delivered at home, better function with fewer side effects, and greater access to clinical trials when standard options are limited.